Monomer Bio

Wow wow wow! I'm always really inspired by Science's technologies. I'm 𝘦𝘴𝘱𝘦𝘤𝘪𝘢𝘭𝘭𝘺 excited about the 𝐛𝐢𝐨𝐡𝐲𝐛𝐫𝐢𝐝 𝐧𝐞𝐮𝐫𝐚𝐥 𝐢𝐧𝐭𝐞𝐫𝐟𝐚𝐜𝐞𝐬 𝐜𝐨𝐦𝐛𝐢𝐧𝐢𝐧𝐠 𝐦𝐢𝐜𝐫𝐨𝐜𝐡𝐢𝐩 𝐞𝐥𝐞𝐜𝐭𝐫𝐨𝐧𝐢𝐜𝐬 𝐚𝐧𝐝 𝐥𝐢𝐯𝐢𝐧𝐠 𝐜𝐞𝐥𝐥𝐬 they're reporting on in this video. I still got to hands-on bring up their first 𝐫𝐨𝐛𝐨𝐭𝐢𝐜 𝐰𝐨𝐫𝐤𝐜𝐞𝐥𝐥 𝐟𝐨𝐫 𝐬𝐭𝐞𝐦 𝐜𝐞𝐥𝐥-𝐝𝐞𝐫𝐢𝐯𝐞𝐝 𝐧𝐞𝐮𝐫𝐨𝐧𝐬 together with Mark Zhang and Carter Allen in the early days of Monomer Bio. After seeing Alan Mardinly's initial operations get up and running, it's very gratifying to see where they have taken it and what they've accomplished now!

✨ At Monomer, we're deeply grateful to our customers—heroes on the front lines tackling humanity's greatest challenges: 🧬 𝐂𝐮𝐫𝐢𝐧𝐠 𝐠𝐞𝐧𝐞𝐭𝐢𝐜 𝐝𝐢𝐬𝐞𝐚𝐬𝐞𝐬 🧫 𝐔𝐧𝐝𝐞𝐫𝐬𝐭𝐚𝐧𝐝𝐢𝐧𝐠 𝐞𝐦𝐛𝐫𝐲𝐨𝐧𝐢𝐜 𝐝𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 🧠 𝐌𝐚𝐩𝐩𝐢𝐧𝐠 𝐭𝐡𝐞 𝐡𝐮𝐦𝐚𝐧 𝐛𝐫𝐚𝐢𝐧 𝐜𝐨𝐧𝐧𝐞𝐜𝐭𝐨𝐦𝐞 ⏳ 𝐓𝐚𝐦𝐢𝐧𝐠 𝐭𝐡𝐞 𝐝𝐫𝐚𝐠𝐨𝐧-𝐭𝐲𝐫𝐚𝐧𝐭 𝐨𝐟 𝐚𝐠𝐢𝐧𝐠 Our mission is bold: to create groundbreaking tools that unlock the mysteries of living cells, pushing the boundaries of what's possible. By innovating with purpose, we aim to cure diseases and inspire the world with new insights into the intricate workings of life. To our customers: thank you for your relentless dedication and vision. Together, we're shaping the future of science and making the impossible, possible. 🚀 #Innovation #LifeSciences #Gratitude #MonomerMission

🚨 Pharma R&D costs are climbing while returns shrink, threatening the sustainability of drug discovery. According to Deloitte, average R&D costs per asset have jumped by 76% over the past decade, while forecasted peak sales per asset dropped by 30% between 2013 and 2023. This trajectory is unsustainable. 💡 𝘛𝘦𝘤𝘩𝘉𝘪𝘰 𝘤𝘰𝘶𝘭𝘥 𝘣𝘦 𝘵𝘩𝘦 𝘢𝘯𝘴𝘸𝘦𝘳. TechBio can scale up experiments and eliminate candidates early, by leveraging: 1. 𝐀𝐝𝐯𝐚𝐧𝐜𝐞𝐬 𝐢𝐧 𝐛𝐢𝐨𝐥𝐨𝐠𝐲 – Moving from small molecules to biologics and cell therapies is transforming therapeutic possibilities. Increasingly complex disease models generate more accurate results. 2. 𝐏𝐫𝐨𝐥𝐢𝐟𝐞𝐫𝐚𝐭𝐢𝐨𝐧 𝐨𝐟 𝐥𝐚𝐛 𝐚𝐮𝐭𝐨𝐦𝐚𝐭𝐢𝐨𝐧 – Enables high throughput to explore broader solution spaces. 3. 𝐄𝐟𝐟𝐞𝐜𝐭𝐢𝐯𝐞𝐧𝐞𝐬𝐬 𝐨𝐟 𝐦𝐚𝐜𝐡𝐢𝐧𝐞 𝐥𝐞𝐚𝐫𝐧𝐢𝐧𝐠 – With some models now surpassing human performance, ML is guiding smarter, faster decisions. The industry talks a lot about AI in labs. In this recent talk, I introduced a framework for talking about the different levels of lab intelligence: - 𝗟𝗲𝘃𝗲𝗹 𝟱: Artificial General Intelligence - 𝗟𝗲𝘃𝗲𝗹 𝟰: Autonomous - 𝗟𝗲𝘃𝗲𝗹 𝟯: ML-Guided - 𝗟𝗲𝘃𝗲𝗹 𝟮: Data-Centric - 𝗟𝗲𝘃𝗲𝗹 𝟭: Automated - 𝗟𝗲𝘃𝗲𝗹 𝟬: Manual 📽️ Interested in learning more? Comment below for a copy of my slides, or watch the 𝗗𝗔𝗬 𝟮 recording here: https://hubs.la/Q02Y6_vb0 #PharmaInnovation #TechBio #DrugDiscovery #MachineLearning #Automation #Biotech #FutureOfMedicine

I will be joining Monomer Bio and Jimmy Sastra, PhD on Wednesday at the Science and Tech show! Wednesday, November 6th at LabCorp (Monogram Biosciences) 345 Oyster Point Blvd. South San Francisco, CA Time:  2pm - 3:30pm Hope to see you there!

Our founder Jimmy Sastra, PhD will be giving a talk on Nov 6th. Don't miss out! Register now.

📣 Day 2 (November 6th) Keynote Speaker Announcement Come learn about the incredible progress Monomer Bio has made towards a self-driving lab and closed loop automation for cell biology. #labautomation #cellbiology #drugdiscovery https://lnkd.in/gS53-SCV

I had the pleasure of sitting down with Emma Chen at Columbia University student-run 𝐁𝐢𝐨𝐖𝐨𝐫𝐤𝐬 𝐩𝐨𝐝𝐜𝐚𝐬𝐭 to discuss Monomer Bio's work in 𝐡𝐞𝐥𝐩𝐢𝐧𝐠 𝐛𝐢𝐨𝐭𝐞𝐜𝐡𝐬 𝐜𝐫𝐞𝐚𝐭𝐞 𝐧𝐨𝐯𝐞𝐥 𝐜𝐞𝐥𝐥 𝐦𝐨𝐝𝐞𝐥𝐬 𝐚𝐧𝐝 𝐠𝐞𝐧𝐞𝐫𝐚𝐭𝐞 𝐬𝐭𝐫𝐮𝐜𝐭𝐮𝐫𝐞𝐝 𝐝𝐚𝐭𝐚. 🧫🔬📊 I always enjoy hearing from undergraduates about their study choices and am impressed by Emma's passion for sharing knowledge through initiatives like her podcast. They are the future, and it's clear that the future is bright. 🌠 Check out our conversation here: https://hubs.ly/Q02W9W980 🎙️🎧

At Monomer, we strive to equip stem cell biologists with tools that allow them to run more experiments and generate better data with less manual effort. We recently released Culture Monitor - a cloud-based solution for monitoring automated stem cell culture and engineering workflows. This solution seamlessly integrates with our Automation Platform and lets researchers make decisions based on the health, morphology, and growth rate of their cultures in near real-time. The Culture Monitor augments automated cell culture systems by providing scientists with: Near Real-time Monitoring — Gain continuous insights into your stem cell cultures. Monitor critical parameters like cell morphology, % confluence, and growth rate in near real-time. Data Analytics and Visualization — Make informed decisions about your cultures with robust analytics. Easily browse images, identify anomalies, and view trends. Remote Access and Control — Stay connected to your experiments from anywhere with our secure cloud-based platform. Access real-time data, receive alerts, and adjust culture conditions remotely. Cloud-Based Data Management — Securely store, view, and share microscopy images from anywhere. Enhanced Quality Control — Ensure consistent and reproducible results with standardized protocols. Want to learn more? Get in touch! https://hubs.ly/Q02VKfS70

At Monomer Bio we're passionate about helping our customers automate complex stem cell culture and engineering workflows in the pursuit of creating better, human-centered disease models for downstream experimentation. Cell-based disease models allow our customers to replicate human disease in a dish and offer a promising new approach for discovering and developing therapeutics for genetic conditions. Are you interested in building a Disease Model Factory in your lab? Get in touch to see a live demo of our solution. #cellculture #stemcells #labautomation #ipsc #diseasemodels #invitromodels #differentiation #organoids

Today we're really excited to launch our new, updated website! Check it out at monomerbio.com 👀 👀 We're also hitting the conference circuit this week. Find us at Meeting on the Mesa (via the partnering app) or the Society for Neuroscience (booth 100 with Cephla). 🚀 #labautomation #cellculture #ipsc #meetingonthemesa24 #sfn24